Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Global Blood Therapeutics, Inc. - Common Stock (NQ:GBT)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 4, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Global Blood Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 20) Alnylam Pharmaceuticals,... 
Via Benzinga
News headline image
Global Blood Therapeutics: Return On Capital Employed Insights ↗
During Q1, Global Blood Therapeutics's (NASDAQ:GBT) reported sales totaled $39.04 million. Despite a 20.83% in earnings, the company posted a loss of $71.03 million. Global Blood... 
Via Benzinga
News headline image
Why Global Blood Therapeutics Moved Higher Wednesday ↗
The pharmaceutical company, which specializes in therapies to fight sickle cell disease, rose nearly 8% on Wednesday. 
Via The Motley Fool
News headline image
Earnings Scheduled For May 5, 2021 ↗
Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter. • EyePoint Pharmaceuticals (NASDAQ:EYPT... 
Via Benzinga
News headline image
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15) IVERIC bio, Inc. (NASDAQ:... 
Via Benzinga
Topics Stocks
News headline image
The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 30) Ambrx Biopharma Inc. (NYSE... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
During Wednesday's morning session, 29 stocks hit new 52-week lows. Points of Interest: The largest company by market cap to set a new 52-week low was CoStar Gr (... 
Via Benzinga
News headline image
Looking Into Global Blood Therapeutics's Return On Capital Employed ↗
In Q1, Global Blood Therapeutics (NASDAQ:GBT) posted sales of $39.04 million. Earnings were up 20.83%, but Global Blood Therapeutics still reported an overall loss of $71.03... 
Via Benzinga
News headline image
The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 29) 10x Genomics, Inc. (NASDAQ... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Gainers Intellia Therapeutics (NASDAQ:NTLA 
Via Benzinga
News headline image
The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 28) Alexion Pharmaceuticals,... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
Before 10 a.m. ET on Monday, 7 stocks hit new 52-week lows. Noteworthy Mentions: The largest company in terms of market cap to set a new 52-week low was CoStar Gr (... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2021 ↗
Upgrades For Toll Brothers Inc (NYSE: 
Via Benzinga
News headline image
14 Biotech Stocks To Watch Over The Next 6 Months ↗
Biotechs are at the mercy of several make-or-break catalysts that invariably have a big impact on stocks. A case in point was the strong upside in Biogen Inc.'s (NASDAQ:... 
Via Benzinga
News headline image
The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck ↗
Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical Oncology meeting got underway during the week,... 
Via Benzinga
News headline image
Vaccine Stocks Call For Billions In Sales Even As Covid Resisters Dig In: IBD/TIPP Poll ↗
The number of people resistant to receiving a Covid vaccine didn't budget in May, according to the IBD/TIPP Poll. But vaccine stocks aren't sweating it, experts say. 
Via Investor's Business Daily
News headline image
Global Blood Therapeutics Q1 Earnings Miss Estimates On Disappointing Sales For Its Sickle-Cell Disease Drug ↗
Global Blood Therapeutics Inc (NASDAQ: GBT) reported a Q1 EPS loss of ($1.21) wider than the anticipated loss estimate of $1.01. Q1 sales of $39.04 million... 
Via Benzinga
Topics Earnings
News headline image
Why Global Blood Therapeutics Stock Is Sinking Today ↗
The company reported disappointing sales for its sickle-cell disease drug. 
Via The Motley Fool
News headline image
Global Blood Therapeutics (GBT) Q1 2021 Earnings Call Transcript ↗
GBT earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
A Peek Into The Markets: US Stock Futures Edge Higher; Bank Earnings In Focus ↗
Pre-open movers U.S. stock futures traded slightly higher in early pre-market trade after the Nasdaq jumped over 1% in the previous session. Investors are awaiting earnings... 
Via Benzinga
News headline image
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2021 ↗
Upgrades For Cardlytics Inc (NASDAQ:CDLX), Craig-Hallum upgraded the previous rating of Hold to Buy. For the fourth quarter, Cardlytics had an EPS of $0.05, compared to... 
Via Benzinga
News headline image
Global Blood Therapeutics' Sickle Cell Med Results In Rapid, Durable Improvements In Hemoglobin Levels Throughout 72 Weeks Of Treatment ↗
Global Blood Therapeutics Inc (NASDAQ: GBT) has announced The Lancet Haematology has published the complete analysis of 72-week data from the Phase 3 HOPE... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.